Return On Assets of NovaBay Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NovaBay Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • NovaBay Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 55%.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2024 was -174%, a 138% decline from 2023.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2023 was -73%, a 47% decline from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Return On Assets for 2022 was -50%, a 37% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NovaBay Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 55% +237% 01 Jul 2025 30 Sep 2025
Q2 2025 55% +192% 01 Apr 2025 30 Jun 2025
Q1 2025 69% +172% 01 Jan 2025 31 Mar 2025
Q4 2024 -174% -101% -138% 01 Oct 2024 31 Dec 2024
Q3 2024 -182% -91% -99% 01 Jul 2024 30 Sep 2024
Q2 2024 -137% -67% -97% 01 Apr 2024 30 Jun 2024
Q1 2024 -103% -38% -58% 01 Jan 2024 31 Mar 2024
Q4 2023 -73% -23% -47% 01 Oct 2023 31 Dec 2023
Q3 2023 -91% -80% -728% 01 Jul 2023 30 Sep 2023
Q2 2023 -70% -47% -205% 01 Apr 2023 30 Jun 2023
Q1 2023 -65% -41% -175% 01 Jan 2023 31 Mar 2023
Q4 2022 -50% -13% -37% 01 Oct 2022 31 Dec 2022
Q3 2022 -11% +43% +79% 01 Jul 2022 30 Sep 2022
Q2 2022 -23% +33% +59% 01 Apr 2022 30 Jun 2022
Q1 2022 -24% +50% +68% 01 Jan 2022 31 Mar 2022
Q4 2021 -36% +44% +55% 01 Oct 2021 31 Dec 2021
Q3 2021 -54% +40% +43% 01 Jul 2021 30 Sep 2021
Q2 2021 -56% +19% +25% 01 Apr 2021 30 Jun 2021
Q1 2021 -74% -11% -18% 01 Jan 2021 31 Mar 2021
Q4 2020 -80% +4.9% +5.7% 01 Oct 2020 31 Dec 2020
Q3 2020 -94% -18% -24% 01 Jul 2020 30 Sep 2020
Q2 2020 -74% +22% +23% 01 Apr 2020 30 Jun 2020
Q1 2020 -62% +21% +25% 01 Jan 2020 31 Mar 2020
Q4 2019 -85% -27% -47% 01 Oct 2019 31 Dec 2019
Q3 2019 -76% -37% -94% 01 Jul 2019 30 Sep 2019
Q2 2019 -97% -50% -109% 01 Apr 2019 30 Jun 2019
Q1 2019 -83% -36% -77% 01 Jan 2019 31 Mar 2019
Q4 2018 -58% +6.7% +10% 01 Oct 2018 31 Dec 2018
Q3 2018 -39% +38% +49% 01 Jul 2018 30 Sep 2018
Q2 2018 -46% +34% +43% 01 Apr 2018 30 Jun 2018
Q1 2018 -47% +49% +51% 01 Jan 2018 31 Mar 2018
Q4 2017 -65% +59% +48% 01 Oct 2017 31 Dec 2017
Q3 2017 -77% +118% +61% 01 Jul 2017 30 Sep 2017
Q2 2017 -81% +210% +72% 01 Apr 2017 30 Jun 2017
Q1 2017 -96% +193% +67% 01 Jan 2017 31 Mar 2017
Q4 2016 -124% +128% +51% 01 Oct 2016 31 Dec 2016
Q3 2016 -195% 01 Jul 2016 30 Sep 2016
Q2 2016 -290% 01 Apr 2016 30 Jun 2016
Q1 2016 -289% 01 Jan 2016 31 Mar 2016
Q4 2015 -252% 01 Oct 2015 31 Dec 2015

NovaBay Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -174% -101% -138% 01 Jan 2024 31 Dec 2024
2023 -73% -23% -47% 01 Jan 2023 31 Dec 2023
2022 -50% -13% -37% 01 Jan 2022 31 Dec 2022
2021 -36% +44% +55% 01 Jan 2021 31 Dec 2021
2020 -80% +4.9% +5.7% 01 Jan 2020 31 Dec 2020
2019 -85% -27% -47% 01 Jan 2019 31 Dec 2019
2018 -58% +6.7% +10% 01 Jan 2018 31 Dec 2018
2017 -65% +59% +48% 01 Jan 2017 31 Dec 2017
2016 -124% +128% +51% 01 Jan 2016 31 Dec 2016
2015 -252% -129% -104% 01 Jan 2015 31 Dec 2015
2014 -123% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.